The market problem

• ~2 million critical Hospital Associated Infections cause ~100,000 deaths and cost ~$30 billion per year
• Two types of bacteria (MRSA and C. difficile) cause nearly half of all fatal infections
• Rapid and sensitive detection has been shown to significantly lower Hospital Associated Infections
• Current diagnostics fail to meet the market need for rapid, sensitive, easy-to-use, and cost-effective tests
• Microbiological tests are too slow, rapid immunoassays are insensitive, nucleic acid tests are too expensive

First Light’s Solution

• First automated platform delivering speed, sensitivity, ease-of-use, cost-effectiveness, on-demand testing
• Simple benchtop MultiPath analyzer supports a menu of consumable cartridges for detecting a broad range of resistant bacteria, toxins, and viruses
• Pipeline tests for key agents causing hospital infections (e.g., MRSA, C. difficile, VRE)
• Product applications include: screening, blood infections, surgical infections, skin infections, GI infections